title: Varenicline modulates spatial working memory deficits in smokers with schizophrenia.
authors.forename: Victoria C
authors.initials: VC
authors.lastname: Wing
authors.forename: Caroline E
authors.initials: CE
authors.lastname: Wass
authors.forename: Ingrid
authors.initials: I
authors.lastname: Bacher
authors.forename: Rachel A
authors.initials: RA
authors.lastname: Rabin
authors.forename: Tony P
authors.initials: TP
authors.lastname: George
mesh_terms: D000704:Analysis of Variance; D001552:Benzazepines / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D008569:Memory Disorders / Q000188:drug therapy* / Q000209:etiology; D009483:Neuropsychological Tests; D018722:Nicotinic Agonists / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011810:Quinoxalines / Q000627:therapeutic use*; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy; D012565:Schizophrenic Psychology; D012907:Smoking / Q000188:drug therapy* / Q000523:psychology; D000068580:Varenicline
chemical_list: D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D000068580:Varenicline